Mechanism investigation and mass spectrometry (MS) experiments revealed that GIPC2 interacted with WNT receptor Fzd7 through its PDZ domain and showed the oncogenic activity by activating WNT-β-catenin regulatory axis during PCa metastasis. The gene discussed is GIPC2; the disease is posterior cortical atrophy.